Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates
暂无分享,去创建一个
Norman L. Letvin | Persephone Borrow | Nicola Ternette | Benedikt M. Kessler | Sheila M. Keating | Xutao Deng | R. Desrosiers | J. Lifson | R. Johnson | N. Letvin | P. Borrow | M. Piatak | Shiquan Wu | B. Kessler | Maurus de la Rosa | S. L. Finstad | Xutao Deng | S. Keating | N. Ternette | Roland C. Zahn | Jeffrey D. Lifson | P. Norris | J. E. Schmitz | Michael Piatak | Ronald C. Desrosiers | Andrea R. Stacey | Philip J. Norris | Maurus de la Rosa | J. Heitman | Joern E. Schmitz | Angela Carville | R. Paul Johnson | John W. Heitman | Shiquan Wu | Samantha L. Finstad | Marie-Claire Gauduin | M. Gauduin | A. Stacey | A. Carville | R. Zahn | M. Rosa | R. Johnson | S. Finstad | Roland Zahn | P. Norris
[1] R P Johnson,et al. Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Barratt-Boyes,et al. Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques , 2016, European journal of immunology.
[3] D. Montefiori,et al. Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. , 2010, Blood.
[4] C. Williamson,et al. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression , 2010, AIDS.
[5] J. Lifson,et al. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.
[6] G. Beall,et al. Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.
[7] J. Eiros,et al. Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[8] M. Johnson,et al. Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case–control analysis nested in a large clinical trial , 2015, AIDS.
[9] J. Altman,et al. IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses1 , 2008, The Journal of Immunology.
[10] A. MacNeil,et al. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus. , 2012, Virology.
[11] P. Fultz,et al. Pathogenicity and comparative evolution in vivo of the transitional quasispecies SIVsmmPBj8. , 1999, Virology.
[12] S. Frøland,et al. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection. , 1997, The Journal of infectious diseases.
[13] Y. Benjamini. Discovering the false discovery rate , 2010 .
[14] Simon A. Jones,et al. Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.
[15] V. Maino,et al. Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.
[16] D. Weiner,et al. Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239. , 2006, Vaccine.
[17] P. Katsikis,et al. The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point? , 2011, PLoS pathogens.
[18] S. Staprans,et al. Severe Depletion of Mucosal CD4+ T Cells in AIDS-Free Simian Immunodeficiency Virus-Infected Sooty Mangabeys1 , 2007, The Journal of Immunology.
[19] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[20] J. Clements,et al. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: From mechanism to treatment , 2011, Journal of NeuroVirology.
[21] Mila Lebedeva,et al. Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.
[22] F. Barré-Sinoussi,et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. , 2005, The Journal of clinical investigation.
[23] David M. Rocke,et al. Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection , 2005, Journal of Virology.
[24] G. Silvestri,et al. Early Divergence in Lymphoid Tissue Apoptosis between Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections of Nonhuman Primates , 2007, Journal of Virology.
[25] P. Choyke,et al. Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection , 2015, Nature Communications.
[26] M. Nowak,et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection , 1997, Journal of virology.
[27] R. Desrosiers,et al. Animal models for acquired immunodeficiency syndrome. , 1987, Reviews of infectious diseases.
[28] Persephone Borrow,et al. The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.
[29] Lloyd H. Michael,et al. The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.
[30] G. Trinchieri,et al. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.
[31] A. Lackner,et al. Visualizing Cytokine-Secreting Cells In Situ in the Rhesus Macaque Model of Chronic Gut Inflammation , 2005, Clinical Diagnostic Laboratory Immunology.
[32] D. Weissman,et al. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation , 1996, The Journal of experimental medicine.
[33] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[34] D. Douek,et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts , 2009, Nature Medicine.
[35] K. Farrell,et al. Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo. , 1993, Journal of clinical immunology.
[36] Carole R. Baskin,et al. Transcriptional Profiling in Pathogenic and Non-Pathogenic SIV Infections Reveals Significant Distinctions in Kinetics and Tissue Compartmentalization , 2009, PLoS pathogens.
[37] J. Lifson,et al. Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques. , 2015, The Journal of clinical investigation.
[38] C. Apetrei,et al. Where the Wild Things Are: Pathogenesis of SIV Infection in African Nonhuman Primate Hosts , 2010, Current HIV/AIDS reports.
[39] S. Staprans,et al. Simian Immunodeficiency Virus Replicates to High Levels in Naturally Infected African Green Monkeys without Inducing Immunologic or Neurologic Disease , 2001, Journal of Virology.
[40] N. Liabakk,et al. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. , 1994, Blood.
[41] Lesego Gabaitiri,et al. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. , 2013, AIDS research and human retroviruses.
[42] R. Desrosiers,et al. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.
[43] B. Haynes,et al. Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection , 2010, PLoS pathogens.
[44] L. Picker,et al. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, The Journal of experimental medicine.
[45] A S Perelson,et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.
[46] Robert M. Grant,et al. Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection , 1999, Journal of Virology.